HCM
BSX icon

Highbridge Capital Management’s Boston Scientific BSX Stock Holding History

Highbridge Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,200
Closed -$333K – 950
2018
Q1 		$333K Buy
+12,200
New +$332K 0.01% 823
2013
Q3 		– Sell
-60,400
Closed -$560K – 1276
2013
Q2 		$560K Buy
+60,400
New +$512K 0.01% 850

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Highbridge Capital Management's BSX Position: Q4 2018 in Review

Highbridge Capital Management sold out of Boston Scientific (BSX) in Q4 2018, closing a stake of 111,475 shares — an estimated $4.29M sold.

Highbridge Capital Management first reported a position in BSX in Q3 2013 and held it in 11 quarters. The position peaked at $30.6M in Q1 2015. 731 funds tracked by Wall St. Rank hold BSX as of Q4 2018.

  • Highbridge Capital Management reported no remaining Boston Scientific position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 111,475 Boston Scientific shares in Q4 2018, an estimated $4.29M.
  • Highbridge Capital Management first reported a position in Boston Scientific in Q3 2013 and held it in 11 quarters.
  • Highbridge Capital Management's Boston Scientific position peaked at $30.6M in Q1 2015.
  • 731 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.